Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment

G, A., ORDU Ç., D, S., F, Ç., ERDOĞAN Z., AĞACAYAK F., ...More

EUR J SUR ONCOL, 01 May 2015, vol.94

  • Publication Type: Conference Paper / Summary Text
  • Volume: 94
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No